Cargando…
Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity
OBJECTIVES: Examine possible pooling strategies designed to expand SARS-CoV-2 serological testing capacity. METHODS: Negative pools were assessed to determine optimal optical density (OD) cutoffs, followed by spiking weak or strong positive samples to assess initial assay performance. Samples were t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575425/ https://www.ncbi.nlm.nih.gov/pubmed/33096207 http://dx.doi.org/10.1016/j.tracli.2020.10.008 |
_version_ | 1783597806684995584 |
---|---|
author | Allen, J.W.L. Verkerke, H. Owens, J. Saeedi, B. Boyer, D. Shin, S. Roback, J.D. Neish, A.S. Stowell, S.R. |
author_facet | Allen, J.W.L. Verkerke, H. Owens, J. Saeedi, B. Boyer, D. Shin, S. Roback, J.D. Neish, A.S. Stowell, S.R. |
author_sort | Allen, J.W.L. |
collection | PubMed |
description | OBJECTIVES: Examine possible pooling strategies designed to expand SARS-CoV-2 serological testing capacity. METHODS: Negative pools were assessed to determine optimal optical density (OD) cutoffs, followed by spiking weak or strong positive samples to assess initial assay performance. Samples were then randomly subjected to pool and individual testing approaches. RESULTS: Single positive specimens consistently converted pools of 5, 10, or 20 into positive outcomes. However, weaker IgG-positive samples failed to similarly convert pools of 50 to a positive result. In contrast, a stronger individual positive sample converted all pools tested into positive outcomes. Finally, examination of 150 samples configured into pools of 5, 10, 20 or 50 accurately predicted the presence of positive or negative specimens within each pool. CONCLUSIONS: These results suggest that pooling strategies may allow expansion of serological testing capacity. While limitations exist, such strategies may aid in large-scale epidemiological screening or identification of optimal convalescent plasma donors. |
format | Online Article Text |
id | pubmed-7575425 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75754252020-10-21 Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity Allen, J.W.L. Verkerke, H. Owens, J. Saeedi, B. Boyer, D. Shin, S. Roback, J.D. Neish, A.S. Stowell, S.R. Transfus Clin Biol Original Article OBJECTIVES: Examine possible pooling strategies designed to expand SARS-CoV-2 serological testing capacity. METHODS: Negative pools were assessed to determine optimal optical density (OD) cutoffs, followed by spiking weak or strong positive samples to assess initial assay performance. Samples were then randomly subjected to pool and individual testing approaches. RESULTS: Single positive specimens consistently converted pools of 5, 10, or 20 into positive outcomes. However, weaker IgG-positive samples failed to similarly convert pools of 50 to a positive result. In contrast, a stronger individual positive sample converted all pools tested into positive outcomes. Finally, examination of 150 samples configured into pools of 5, 10, 20 or 50 accurately predicted the presence of positive or negative specimens within each pool. CONCLUSIONS: These results suggest that pooling strategies may allow expansion of serological testing capacity. While limitations exist, such strategies may aid in large-scale epidemiological screening or identification of optimal convalescent plasma donors. Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2021-02 2020-10-21 /pmc/articles/PMC7575425/ /pubmed/33096207 http://dx.doi.org/10.1016/j.tracli.2020.10.008 Text en © 2020 Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Allen, J.W.L. Verkerke, H. Owens, J. Saeedi, B. Boyer, D. Shin, S. Roback, J.D. Neish, A.S. Stowell, S.R. Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title | Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title_full | Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title_fullStr | Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title_full_unstemmed | Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title_short | Serum pooling for rapid expansion of anti-SARS-CoV-2 antibody testing capacity |
title_sort | serum pooling for rapid expansion of anti-sars-cov-2 antibody testing capacity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575425/ https://www.ncbi.nlm.nih.gov/pubmed/33096207 http://dx.doi.org/10.1016/j.tracli.2020.10.008 |
work_keys_str_mv | AT allenjwl serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT verkerkeh serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT owensj serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT saeedib serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT boyerd serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT shins serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT robackjd serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT neishas serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity AT stowellsr serumpoolingforrapidexpansionofantisarscov2antibodytestingcapacity |